Health for Life Capital II, a new Microbiome Fund by Seventure
Seventure Partners, one of Europe’s leading venture capital firm, financing innovation and a world-leader in life science microbiome investment, announces it has completed the first closing of its second dedicated fund focused on the microbiome, and health, nutrition and digital/connected health sectors, Health for Life Capital IITM (HFL II), with a target for the final close of over €200 million.
See here for further information.
Seventure invests in Microbiome-linked innovations, nutrition, foodtech, digital/connected health and personalized medicine. Investments can range between €500k and €10m per round, or up to €20m per company, from early to late stage.